Rekvina Laboratories Limited reported unaudited standalone earnings results for the second quarter and six months ended September 30, 2018. For the quarter, the company reported loss before exceptional items and tax was INR 0.011 million against INR 0.045 million a year ago. Loss for the period from continuing operations was INR 0.011 million against INR 0.045 million a year ago. For the six months, the company reported loss before exceptional items and tax was INR 0.350 million against INR 0.248 million a year ago. Loss for the period from continuing operations was INR 0.350 million against INR 0.248 million a year ago.